Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)

Clinical trial NCT06676579 · RECRUITING

Trial details

NCT number: NCT06676579
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

IgA Nephropathy (IgAN)

Start date: 2025-06-09
Primary completion: 2028-03-02
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.